🇺🇸 FDA
Patent

US 11161875

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

granted A61KA61K31/497A61K38/00

Quick answer

US patent 11161875 (Inhibition of pulmonary fibrosis with nutlin-3a and peptides) held by The Board of Regents of the University of Texas System expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/497, A61K38/00, A61K38/08, A61K38/177